22
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Investigation of Quality in Ephedrine-Containing Dietary Supplements

(Professor of Experimental and Clinical Pharmacology) (Senior Investigator) (Director of Preclinical Research) (Associate Scientist) (Assistant Professor) (Associate Investigator) (Professor of Experimental and Clinical Pharmacology) (Senior Investigator) (Director of Preclinical Research) (Associate Scientist) (Assistant Professor) (Associate Investigator) (Professor of Experimental and Clinical Pharmacology) (Senior Investigator) (Director of Preclinical Research) (Associate Scientist) (Assistant Professor) (Associate Investigator) (Professor of Experimental and Clinical Pharmacology) (Senior Investigator) (Director of Preclinical Research) (Associate Scientist) (Assistant Professor) (Associate Investigator) (Professor of Experimental and Clinical Pharmacology) (Senior Investigator) (Director of Preclinical Research) (Associate Scientist) (Assistant Professor) (Associate Investigator) (Professor of Experimental and Clinical Pharmacology) (Senior Investigator) (Director of Preclinical Research) (Associate Scientist) (Assistant Professor) (Associate Investigator) , , &
Pages 5-17 | Published online: 20 Aug 2009

References

  • Karch S B. Ma-huang and the ephedra alkaloids. Toxicology and Clinical Pharmacology of Herbal Products, M J Cupp. Humana Press, Totowana, NJ 2000; 11–30
  • United States Pharmacopeia: Drug Information for the Health Professional, Vol. 1. Micromedex, Greenwood Village, CO 2002
  • Gurley B J, Wang P, Gardner S F. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (ma-huang) as determined by high performance liquid chromatography. J Pharm Sci. 1998; 87: 1547–1553
  • Josefson D. Herbal stimulant causes U.S. deaths. Br Med J. 1996; 312: 1378–1379
  • Doyle H, Kargin M. Herbal stimulant containing ephedrine has also caused psychosis. Br Med J. 1996; 313: 756
  • Nightingale S L. Warning issued about street drugs containing botanical sources of ephedrine. J Am Med Assoc. 1996; 275: 1534
  • Nadir A, Agarawal S, King P D, Marchall J B. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol. 1996; 91: 1436–1438
  • Ault A. FDA proposes limits on ephedrine supplements. Lancet 1997; 349: 1753
  • Bunten W. A call for self-regulation. J Am Pharm Assoc. 1999; 39: 14
  • Hahm H, Kujawa J, Augsburger L. Comparison of melatonin products against USP's nutritional supplements standards and other criteria. J Am Pharm Assoc. 1999; 39: 27–31
  • Parasrampuria J, Schwartz K. Quality control of dehydroepiandrosterone dietary supplement products. JAMA 1998; 280: 1565
  • Liberti L E, Der Marderosian A. Evaluation of commercial ginseng products. J Pharm Sci. 1978; 67: 1487–1489
  • King A B. The dietary supplement health and education act of 1994: Focus on labeling issues. Nutrition 1997; 13: 999–1001
  • Special Report. Dietary supplements: Recent chronology and legislation. Nutr Rev. 1995; 53: 31–36
  • Gurley B J, Gardner S F, Bubbard M A. Content versus label claims in Ephedra-containing dietary supplements. Am J Health Syst Pharm. 2000; 57: 963–969
  • Betz J M, Gay M L, Mossoba M M, Adams S, Portz B S. Chiral gas chromato-graphic determination of ephedrine-type alkaloids in dietary supplements containing ma-huang. JAOAC Int. 1997; 80(2)303–315
  • Hurlbut J A, Carr J R. Solid-phase extraction cleanup and liquid chromatogra-phy with ultraviolet detection of ephedrine alkaloids in herbal products. JAOAC Int. 1998; 81(6)1121–1127
  • Liu Y-M, Sheu S-J, Chiou S-H, Chang H-C, Chen Y-P. A comparative study on commercial samples of Ephedrae herba. Planta Med. 1993; 59: 376–378
  • Anonymous. Dietary supplements containing ephedrine alkaloids: Proposed Rule. 21 CFR 111. Fed Register 1997; 62(107)30677–30724
  • Eisenberg D M, Davis R B, Ettner S L, Appel S, Wilkey S, Van Rompay M, Kessler R C. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998; 280: 1569–1575

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.